NCT02193815 - A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Psoriasis Vulgaris

Interventions

DRUG

PF06263276

4% PF 06263276 solution Daily dosage: approximately 8 mg PF 06263276 QD

OTHER

Vehicle

Active ingredient-free vehicle to 4% solution

DRUG

2%Tofacitinib Ointment

Daily Dosage: approximately 4 mg tofacitinib

OTHER

Vehicle

Active ingredient-free vehicle to 2% Ointment

DRUG

Daivonex

Daivonex solution (50 ug/ml Calcipotriol) Daily Dosage of calcipotriol: approximately 0.01 mg

DRUG

Daivonex Ointment

Daivonex ointment (50 ug/g Calcipotriol) Daily Dosage of calcipotriol: approximately 0.01 mg

Trial Locations (1)

Bioskin GmbH, Hamburg